Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward F Fritsch

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Genes and Immunity|December 11, 2023
Serving up whatever you wish: CRISPR-base editing generates novel cancer-restricted antigens for immunotherapyUte E Burkhardt, Edward F Fritsch
Cancer Research|April 1, 2024
Personalized Cancer Vaccines Directed against Tumor Mutations: Building Evidence from Mice to HumansEdward F Fritsch, Patrick A Ott
Blood Cancer Discovery|January 11, 2022
Cancer and COVID-19: On the Quest for Effective VaccinesMarwan Kwok, Edward F Fritsch, Catherine J Wu
Oncoimmunology|August 8, 2014
Personal neoantigen cancer vaccines: The momentum buildsEdward F Fritsch, Nir Hacohen, Catherine J Wu
Cell|July 14, 2022
Cancer vaccines: Building a bridge over troubled watersMacLean C Sellars, Catherine J Wu, Edward F Fritsch
Cancer Immunology Research|December 2, 2020
Personal Neoantigen Cancer Vaccines: A Road Not Fully PavedEdward F Fritsch, Ute E Burkhardt, Nir Hacohen, et al.
Hematology/Oncology Clinics of North America|June 2, 2014
Vaccines and melanomaPatrick A Ott, Edward F Fritsch, Catherine J Wu, et al.
Cancer Immunology Research|April 30, 2014
Getting personal with neoantigen-based therapeutic cancer vaccinesNir Hacohen, Edward F Fritsch, Todd A Carter, et al.
Cancer Immunology Research|June 5, 2014
HLA-binding properties of tumor neoepitopes in humansEdward F Fritsch, Mohini Rajasagi, Patrick A Ott, et al.
Nature Medicine|March 12, 2026
Clinical development of cancer vaccinesJohn B Haanen, Ton N M Schumacher, Jonathan C Kagan, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Genes and Immunity|December 11, 2023
Serving up whatever you wish: CRISPR-base editing generates novel cancer-restricted antigens for immunotherapyUte E Burkhardt, Edward F Fritsch
Cancer Research|April 1, 2024
Personalized Cancer Vaccines Directed against Tumor Mutations: Building Evidence from Mice to HumansEdward F Fritsch, Patrick A Ott
Blood Cancer Discovery|January 11, 2022
Cancer and COVID-19: On the Quest for Effective VaccinesMarwan Kwok, Edward F Fritsch, Catherine J Wu
Oncoimmunology|August 8, 2014
Personal neoantigen cancer vaccines: The momentum buildsEdward F Fritsch, Nir Hacohen, Catherine J Wu
Cell|July 14, 2022
Cancer vaccines: Building a bridge over troubled watersMacLean C Sellars, Catherine J Wu, Edward F Fritsch
Cancer Immunology Research|December 2, 2020
Personal Neoantigen Cancer Vaccines: A Road Not Fully PavedEdward F Fritsch, Ute E Burkhardt, Nir Hacohen, et al.
Hematology/Oncology Clinics of North America|June 2, 2014
Vaccines and melanomaPatrick A Ott, Edward F Fritsch, Catherine J Wu, et al.
Cancer Immunology Research|April 30, 2014
Getting personal with neoantigen-based therapeutic cancer vaccinesNir Hacohen, Edward F Fritsch, Todd A Carter, et al.
Cancer Immunology Research|June 5, 2014
HLA-binding properties of tumor neoepitopes in humansEdward F Fritsch, Mohini Rajasagi, Patrick A Ott, et al.
Nature Medicine|March 12, 2026
Clinical development of cancer vaccinesJohn B Haanen, Ton N M Schumacher, Jonathan C Kagan, et al.
Pageof 3